How we have 201 tumor samples which have avg_consensus_idx > 0.9 in CC_IFS of ComBat248, and the new ComBat201 has cophenetic = 1.
Thus we can lower the avg_consensus_idx cutoff to include more samples until cophenetic < 1.
24% of M patients benifit from chemo.
30% of D patients may benifit from PI3K?
46% treatment unknow?
No comments:
Post a Comment